Institute for Molecular Science of Medicine, Aichi Medical University School of Medicine, Yazako, Nagakute, Japan.
Int Arch Allergy Immunol. 2010;153(3):223-33. doi: 10.1159/000314362. Epub 2010 May 18.
Serum-derived hyaluronan (HA)-associated proteins (SHAPs), the heavy chains of inter-α-trypsin inhibitor, covalently bind to HA to form the SHAP-HA complex. The SHAP-HA complex is involved in the pathophysiology of inflammatory diseases, including rheumatoid arthritis. We investigated whether this complex is also involved in airway allergy.
SHAP-HA-deficient (bikunin knockout, KO) mice and wild-type (WT) mice were immunized twice by intraperitoneal injection of ovalbumin (OVA) and exposed to aerosol OVA for 30 min each day for 2 weeks. Twenty-four hours after the final OVA challenge, airway responsiveness to inhaled methacholine (MCh) was measured, and analysis of bronchoalveolar lavage fluid (BALF) and lung histological studies were done.
Compared to WT mice, KO mice showed higher airway hyperresponsiveness to inhaled MCh and higher late-phase responses to OVA whereas the early-phase responses were similar. Cell differentials of BALF showed an increased number of macrophages and neutrophils in KO mice. Furthermore, decreased concentrations of soluble tumor necrosis factor receptor-1 (sTNFR1) were found in BALF from KO mice whereas the levels of Th1 and Th2 cytokines were not different from WT mice. Immunochemical study of the lung tissues revealed stronger staining of sTNFR1 in KO than in WT mice.
Our results suggest that in this murine asthma model, the SHAP-HA complex has an inhibitory role in the development of airway hyperresponsiveness and allergic airway inflammation which may be attributed, at least in part, to negative feedback mechanisms exerted by sTNFR1, the shedding of which from the cell surface might also be promoted by the SHAP-HA complex.
血清源性透明质酸(HA)相关蛋白(SHAPs),即α-胰蛋白酶抑制剂重链,与 HA 共价结合形成 SHAP-HA 复合物。SHAP-HA 复合物参与了包括类风湿关节炎在内的炎症性疾病的病理生理学过程。我们研究了该复合物是否也参与了气道过敏。
通过腹腔注射卵清蛋白(OVA)对 SHAP-HA 缺陷( Bikunin 敲除,KO)小鼠和野生型(WT)小鼠进行两次免疫,并每天暴露于气溶胶 OVA 中 30 分钟,持续 2 周。在最后一次 OVA 挑战后 24 小时,测量气道对吸入性乙酰甲胆碱(MCh)的反应性,并进行支气管肺泡灌洗液(BALF)分析和肺组织学研究。
与 WT 小鼠相比,KO 小鼠对吸入性 MCh 的气道高反应性更高,对 OVA 的迟发相反应更高,而早发相反应相似。BALF 细胞分类显示 KO 小鼠的巨噬细胞和中性粒细胞数量增加。此外,KO 小鼠 BALF 中的可溶性肿瘤坏死因子受体-1(sTNFR1)浓度降低,而 Th1 和 Th2 细胞因子水平与 WT 小鼠无差异。肺组织的免疫化学研究显示,KO 小鼠的 sTNFR1 染色强度强于 WT 小鼠。
我们的结果表明,在该小鼠哮喘模型中,SHAP-HA 复合物在气道高反应性和过敏性气道炎症的发展中具有抑制作用,这可能归因于 sTNFR1 的负反馈机制,其从细胞表面脱落也可能受到 SHAP-HA 复合物的促进。